VLPベースのワクチン製造 日本

• 安全で効果的、そしてスケーラブルな製造

  VLP vaccines - VPP begins with construction of a small virus-like particle in the lab. But fear not, because these particles are NOT contagious to humans! Scientists insert tiny bits of the germs that these vaccines will provide protection which is also known as VLPs. 

• VLPベースのワクチンプロセス

  VLP ワクチンはワクチン科学の分野における進歩です。迅速かつ容易に大量生産できるため、緊急事態や病気の発生時に人々を守るための備えが強化されます。また、病気から私たちを安全に守る効果もあります。細菌がほぼ一夜にして進化する今日では、このことはさらに当てはまります。

• VLPベースのワクチンによる免疫力の強化 - 有望な未来

  VLP技術は、新しい技術（COVIDワクチンで使用されているmRNAなど）と組み合わせることもできます。mRNAは、体に指示を与える遺伝物質の一種です。研究者は、mRNAとVLPを組み合わせて使用​​することで、体に細菌とより効果的に戦う方法を教えるワクチンを開発できます。組み合わせることで、より強力なワクチンが得られ、失敗する可能性も低くなります。

Yaohai VLP ベースのワクチン製造を選択する理由は何ですか?

• 品質システムとグローバル規制コンプライアンス

  Yaohai BioPharma is a Top 10 Microbial CDMO that incorporates quality control and regulatory matters. We have a quality system which is in line with current GMP standards and international regulations. Our regulatory team is knowledgeable in global regulatory frameworks to accelerate biological launches. We ensure traceable manufacturing processes and top-quality products that are compliant with the requirements of the US FDA, EU EMA, Australia TGA, and VLP-based Vaccine Manufacturing. Yaohai BioPharma has successfully passed the audit on site of the European Union's qualified Person (QP) for our GMP quality system and production site. In addition, we've cleared the first certification audits of the ISO9001 Quality Management System, ISO14001 Environmental Management System, and ISO45001 Occupational Health and Safety Management System.

• 専門知識と豊富な経験

  Yaohai Bio-Pharma is a leading in VLP-based Vaccine Manufacturing CDMO. Our main focus has been the production of microbial vaccinations and therapeutics to treat pets, human and veterinary health. We possess cutting-edge RD and manufacturing technology platforms that cover the entire manufacturing process from the engineering of microbial strains, to cell banking processing and method design to clinical and commercial manufacturing, making sure that we can ensure the successful delivery of the most advanced solutions. We have accumulated a huge quantity of knowledge in the bio processing microbial field. More than 200 projects have been successfully completed and we help our clients comply with regulations like those of the US FDA as well as EU EMA. We also help them to navigate Australia TGA and China NMPA. We are able to respond rapidly to market requirements and offer customized CDMO services due to our experience and expertise.

• 強力なサプライチェーンと製造能力

  Yaohai Bio-Pharma, a top 10 VLP-based Vaccine Manufacturing of biological products, is a specialist in microbial fermentation. We have set up a modern facility that has robust RD capabilities and advanced infrastructure. Five lines of production for drugs conforming to GMP standards to purify and ferment microbial cells along with two fill and finish lines for vials as well as cartridges and needles pre-filled are readily available. The fermentation scales available for use range from 100L to 2000L. Filling specifications for vias are 1ml to 25ml, whereas pre-filled syringe or cartridge filling requirements are between 1-3ml. The production workshop is cGMP certified and offers the availability of commercial and clinical samples. The large molecules manufactured in our facility are available for delivery worldwide.

• カスタマイズ、効率性、コスト効率

  Yaohai Bio-Pharma has experience in the manufacture of biologics derived from microorganisms. We offer tailored RD solutions and manufacturing while minimizing the risk. We have worked with diverse methods, such as VLP-based Vaccine Manufacturing of vaccines (including peptides), growth factors, hormones, and Cytokines. We specialized in multiple microbial hosts, including yeast extracellular and intracellular (yield up to 15 g/L) bacteria periplasmic secretion, soluble intracellular, and inclusion bodies (yield up to 10 grams/L). We also have a BSL-2 fermentation platform to create bacterial vaccines. We specialize in improving processes, increasing product yields, as well as reducing production costs. We have an efficient technology team that guarantees timely and quality project delivery. This allows us to deliver your exclusive products quicker to market.

関連商品カテゴリー

• AAVプラスミド製造
• プラスミドDNAの分析方法
• バクテリオファージ AP205 VLP 製造
• バクテリオファージQ VLP製造
• キメラVLPワクチン製造
• 結合VLPワクチン製造
• DNAワクチン製造
• VLP生産のための大腸菌発酵
• GLP-1アゴニスト製造
• GLP-1アナログ製造

探しているものが見つかりませんか?
その他の利用可能な製品については、コンサルタントにお問い合わせください。